Index of artpub/2018/pmc_30328061/

Salavert, Miguel
Cost-Effectiveness Analysis of Bezlotoxumab Added to Standard of Care Versus Standard of Care Alone for the Prevention of Recurrent Clostridium difficile Infection in High-Risk Patients in Spain
2018
https://ddd.uab.cat/record/228046
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1=Salavert,_Miguel2022-06-29 13:33 17  
[ ]2=Cost-Effectiveness_Analysis_of_Bezlotoxumab...2022-06-29 13:33 195  
[ ]3=20182022-06-29 13:33 5  
[ ]4=2280462022-06-29 13:33 34  
[TXT]pmc_30328061.dirinfo2024-10-02 04:40 342  
[ ]pmc_30328061.du2024-10-02 04:40 35  
[TXT]pmc_30328061.dupdirs2024-10-02 04:40 0  
[TXT]pmc_30328061.dupfiles2024-10-02 04:40 0  
[TXT]pmc_30328061.errors2024-10-02 04:40 0  
[IMG]pmc_30328061.gif2024-10-02 04:40 75K 
[IMG]pmc_30328061.ico2024-10-02 04:40 12K 
[TXT]pmc_30328061.info2024-10-02 04:40 60K 
[TXT]pmc_30328061.md52024-10-02 04:40 51  
[ ]pmc_30328061.pdf2024-10-02 04:40 1.6M 
[TXT]pmc_30328061.sha12024-10-02 04:40 59  
[TXT]pmc_30328061.sha2562024-10-02 04:40 83  
[TXT]pmc_30328061.stats2024-10-02 04:40 254  
[TXT]pmc_30328061.txt2024-10-02 04:40 57K